同和药业：关于取得发明专利证书的公告

Core Insights - Tonghua Pharmaceutical announced the receipt of two invention patents from the National Intellectual Property Administration, focusing on a regeneration method for phase change deactivated ruthenium carbon catalysts and a preparation method and application for carbon catalytic materials co-doped with single and multi-atom transition metals [1] Group 1 - The company received an invention patent for a regeneration method of phase change deactivated ruthenium carbon catalysts [1] - The second patent pertains to a method for preparing and applying carbon catalytic materials co-doped with single and multi-atom transition metals [1]